Journal
FEBS LETTERS
Volume 582, Issue 25-26, Pages 3590-3594Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.febslet.2008.09.028
Keywords
Apoptosis; B-cell lymphoma-2; Cancer; Bfl-1; A1; Crystal structure
Funding
- Structural Genomics Consortium [1097737]
- Canadian Institutes for Health Research
- Canadian Foundation for Innovation
- Genome Canada through the Ontario Genomics Institute
- GlaxoSmithKline, Karolinska Institutet
- Knut and Alice Wallenberg Foundation
- Ontario Innovation Trust
- Ontario Ministry for Research and Innovation, Merck Co., Inc.
- Novartis Research Foundation
- Swedish Agency for Innovation Systems
- Swedish Foundation for Strategic Research
- Wellcome Trust
- EU-Spine II
- Swedish Cancer Society
- Swedish Research Council (PN)
- Medical Research Council [G0500367] Funding Source: researchfish
- MRC [G0500367] Funding Source: UKRI
Ask authors/readers for more resources
Evasion of apoptosis is recognized as a characteristic of malignant growth. Anti-apoptotic B-cell lymphoma-2 (Bcl-2) family members have therefore emerged as potential therapeutic targets due to their critical role in proliferating cancer cells. Here, we present the crystal structure of Bfl-1, the last antiapoptotic Bcl-2 family member to be structurally characterized, in complex with a peptide corresponding to the BH3 region of the pro-apoptotic protein Bim. The structure reveals distinct features at the peptide-binding site, likely to de. ne the binding pecificity for pro-apoptotic proteins. Superposition of the Bfl-1: Bim complex with that of Mcl-1: Bim reveals a significant local plasticity of hydrophobic interactions contributed by the Bim peptide, likely to be the basis for the multi specificity of Bim for antiapoptotic proteins. (c) 2008 Published by Elsevier B. V. on behalf of the Federation of European Biochemical Societies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available